Evidence map›Paper›PMID 35457367›Full record

ArticleInternational journal of environmental research and public health2022

Optimizing PrEP Continuance: A Secondary Analysis Examining Perceived Autonomy Support and Care Coordination Quality among Black MSM in HPTN 073.

S Raquel Ramos, Geetha Beauchamp, Darrell P Wheeler, Leo Wilton, Darren L Whitfield, Donte T Boyd, Lisa Hightow-Weidman, Sheldon D Fields, LaRon E Nelson, On Behalf Of The Hptn Team

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 2 countries.

S Raquel RamosSchool of Nursing, Yale University, Orange, CT 06477, USA.ORCID 0000-0003-2403-7222
Geetha BeauchampSCHARP, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Darrell P WheelerOffice of the Provost, Iona College, New Rochelle, NY 10801, USA.ORCID 0000-0003-2087-6571
Leo WiltonDepartment of Human Development, State University of New York at Binghamton, Binghamton, NY 13901, USA.
Darren L WhitfieldSchool of Social Work, University of Maryland, Baltimore, MD 21201, USA.
Donte T BoydCollege of Social Work, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-9952-3116
Lisa Hightow-WeidmanDepartment of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Sheldon D FieldsCollege of Nursing, Pennsylvania State University, University Park, PA 16803, USA.
LaRon E NelsonSchool of Nursing, Yale University, Orange, CT 06477, USA.
On Behalf Of The Hptn Team
Binghamton University · USFred Hutch Cancer Center · USIona College · USPennsylvania State University · USSt. Michael's Hospital · CAThe Ohio State University · USUniversity of Maryland, Baltimore · USUniversity of North Carolina at Chapel Hill · USYale University · US

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
LEveraging A viRtual eNvironment (LEARN) to Enhance Prevention of HIV-related Comorbidities, SupplementK01HL145580 · NHLBI · YALE UNIVERSITY · PI RAMOS, SILVIA RAQUEL · 2019 to 2023
$860k
NHLBI NIH HHS K01 HL145580NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIMH NIH HHS R25 MH067127The HIV Prevention Trials Network UM1AI068619, UM1AI068613, UM1AI1068617
6 · The paper itself

Abstract

At the end of year 2018, it was estimated that in the United States over 1 million people were living with HIV. Although Black/African American individuals comprise an estimated 13.4% of the US population, as of 2019, they represented an estimated 42% of all new HIV diagnoses in 2018. PrEP use among Black men who have sex with men has not reached levels sufficient to have a population impact on HIV incidence. The purpose of this study was to examine whether high perceived autonomy support and care coordination quality were associated with PrEP continuation. Secondary analyses were conducted on data with 226 Black MSM in three US cities. Participants who were PrEP users and scored higher on autonomy support at week 8 were significantly more likely to continue PrEP (OR 1.48; 95% CI 1.04-2.11). Perception of coordination quality did not differ between PrEP users and non-users at any of the visits. Although coordination quality was not statistically significant, greater than half of PrEP users and non-PrEP users utilized the C4 services. Addressing social, individual, and structural barriers to PrEP may benefit Black MSM irrespective of their PrEP use.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesBlack or African AmericanHomosexuality, MaleHumansMaleUnited StatesAnti-HIV Agentsautonomy supportBlack MSMcare coordinationdecision makinghealthcare qualityHIVpatient care managementPrEP

Identifiers

PMID35457367
PMCPMC9026517
OpenAlexW4224304371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.